Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioPlete is a healthcare and nutraceutical company focused on developing nutritional solutions for chronic pain management. Its flagship product, BioPlete Advanced Formula, is a specialized supplement designed to address biochemical abnormalities such as chronic inflammation, oxidative stress, and neurotransmitter imbalances commonly found in pain patients. The company operates as a dedicated research and development arm of Ethos Laboratories, utilizing the Foundation Pain Index (FPI) biomarker platform to guide its nutritional interventions. BioPlete's products are marketed as non-pharmaceutical alternatives or adjuncts to traditional pain medications, and the company actively conducts clinical trials to evaluate the efficacy of its formulations in improving the quality of life for patients with chronic pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioPlete.